Green pharmaceuticals; Sustainable development; Environmental resource protection; Taiji Group
Abstract:
Under the background of the “dual-carbon” strategy, the pharmaceutical industry, as an important industry related to public health and ecological security, is facing the dual challenges of high resource consumption and high environmental load. From the perspective of environmental resource protection and sustainable development, this paper systematically sorts out the environmental impact mechanism of the entire life cycle of the pharmaceutical industry, reveals its characteristics of “high energy consumption, high pollution, and high risk”, and combines the national policy system to analyze the institutional guarantee for green transformation. Taking Taiji Group as a typical case, this paper deeply analyzes its practical paths in green planting, energy conservation and carbon reduction, clean technology, resource recycling, and ESG governance, and summarizes its replicable green development model. On this basis, it puts forward hierarchical and classified enterprise green transformation strategies and policy suggestions, such as green drug evaluation, green financial incentives, and multi-regulatory collaboration. The study believes that we should adhere to systematic thinking and whole-process management to promote the organic unity of environmental friendliness, efficient resource utilization, and responsibility fulfillment in the pharmaceutical industry.
Cite: Ma, J. Z., Liu, C. L., Shi, G. (2025). Research on Environmental Resource Protection and Sustainable Paths in Pharmaceutical Development—A Case Study of Taiji Group. Environment and Resource, 7(1), 262-274.